Results 241 to 250 of about 112,243 (300)

Advancing Hepatocellular Carcinoma Therapy with Next-Generation Molecular and Immunotherapeutics. [PDF]

J Hepatocell Carcinoma
Hassan M, Hussain I, Ahmad K, Zafar S, Khalid A, Haseeb M, Hussain N, Ghafar MA.   +7 more
europepmc   +1 more source

Profillin‐1 and Transgelin‐2: Actin Binding Proteins Expression in Early and Advanced Stages of Triple‐Negative Breast Cancer Receiving Neoadjuvant Chemotherapy

Cancer Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background Triple‐negative breast cancer (TNBC) is known for its more aggressive clinical behavior, poor prognosis, and distinctive patterns of metastasis. Neoadjuvant chemotherapy (NAC) can influence both tumor cells and the tumor microenvironment.
Moazzam Ali Shahid, Shamim Mushtaq, Ayesha Khan, Uzma Naseeb, Ghulam Haider, Bushra Wasim   +5 more
wiley   +1 more source

Hairy cell leukemia: a chronic B-cell lymphoma with unique clinicopathological features and unresolved molecular mechanisms. [PDF]

Blood Adv
Zhang G, Hu J.
europepmc   +1 more source

Valorization of Banana Biomass: Nutritional and Phytochemical Insights With Applications in Food and Allied Industries

eFood, Volume 7, Issue 2, April 2026.
Composition, biological activity and food application of banana biomass. ABSTRACT The global banana processing industry generates substantial organic waste in the form of peels, leaves, stems, and flowers, posing both environmental challenges and opportunities for valorization within a circular economy framework.
Bushra Iram Fatima, Saeed Akhtar, Muhammad Zulqarnain Khan, Muhammad Qamar, Tariq Ismail, Wisha Saeed, Elham Assadpour, Tuba Esatbeyoglu, Seid Mahdi Jafari   +8 more
wiley   +1 more source

Extracellular ATP Suppresses Perlecan Core Protein Synthesis via P2Y2 Receptor-Mediated Inhibition of Akt Signaling in Cultured Vascular Endothelial Cells. [PDF]

Int J Mol Sci
Ikeuchi L, Hara T, Kitabatake K, Uchiumi F, Yamamoto C, Tsukimoto M, Fujie T, Kaji T.   +7 more
europepmc   +1 more source

Reprogramming SREBP1‐dependent lipogenesis and inflammation in high‐risk breast with licochalcone A: A novel path to cancer prevention

International Journal of Cancer, Volume 158, Issue 7, Page 1927-1940, 1 April 2026.
What's new? Endocrine drugs repurposed from treatment protocols are the primary medications available for breast cancer (BC) prevention in at‐risk women. Adverse effects, however, significantly minimize uptake and prevention impact. Here, the authors investigated licochalcone A (LicA), a non‐endocrine anti‐inflammatory agent with reported hematologic ...
Atieh Hajirahimkhan, Elizabeth T. Bartom, Carolina H. Chung, Xingyu Guo, Kyli Berkley, Seyyedmohsen Hosseinibarkooie, Zahra Assadi, Shao Huan Samuel Weng, Raymond Moellering, Oukseub Lee, Ruohui Chen, Wonhwa Cho, Sriram Chandrasekaran, Susan E. Clare, Seema A. Khan   +14 more
wiley   +1 more source

NX-1607: lifting the Cbl-b brake to promote T cell activation through MAPK/ERK pathways. [PDF]

J Immunother Cancer
To A, Sugimura R.
europepmc   +1 more source

Skeletal Muscle and Circulating microRNAs Adaptations to 12‐Week HIIT With or Without L‐Citrulline in Obese Older Adults

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 2, April 2026.
ABSTRACT Background High‐intensity interval training (HIIT) with or without L‐citrulline (CIT) oral supplementation improves body composition, functional capacities and muscle health in obese older adults, potentially through microRNA‐driven regulation.
Alexandre Mercier‐Guery, Marjorie Millet, Martine Croset, Vincent Marcangeli, Maude Dulac, Livia P. Carvalho, Guy Hajj‐Boutros, Pierrette Gaudreau, José A. Morais, Gilles Gouspillou, Philippe Noirez, Jean Charles Rousseau, Roland Chapurlat, Mylène Aubertin‐Leheudre   +13 more
wiley   +1 more source

Real-World Health Care Resource Utilization and Costs Among Patients with Activated Phosphoinositide 3-Kinase Delta (PI3Kδ) Syndrome in the United States. [PDF]

Adv Ther
Rider NL, Laliberté F, Germain G, Urosevic A, Mahendran M, Harrington A.   +5 more
europepmc   +1 more source

Antimicrobial Peptides Induce Cell Death in Marginal Zone Lymphoma Models Resistant to Targeted Therapies

eJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Introduction Marginal zone lymphoma (MZL) is an indolent yet incurable B‐cell malignancy in which targeted agents such as BTK and PI3K inhibitors frequently fail due to resistance or toxicity. Antimicrobial peptides (AMPs), evolutionarily conserved effectors of innate immunity, possess selective cytotoxicity against malignant cells by ...
Filippo Spriano, Alberto J. Arribas, Fangwen Zhang, Elisa Civanelli, Maria Luisa Mangoni, Francesco Buonocore, Francesco Bertoni   +6 more
wiley   +1 more source